-
1Academic Journal
المؤلفون: Makrakis D., Bakaloudi D. R., Talukder R., Lin G. I., Diamantopoulos L. N., Jindal T., Vather-Wu N., Zakharia Y., Tripathi N., Agarwal N., Dawsey S., Gupta S., Lu E., Drakaki A., Liu S., Zakopoulou R., Bamias A., Fulgenzi C. -M., Cortellini A., Pinato D., Barata P., Grivas P., Khaki A. R., Koshkin V. S.
المساهمون: Makrakis, D., Bakaloudi, D. R., Talukder, R., Lin, G. I., Diamantopoulos, L. N., Jindal, T., Vather-Wu, N., Zakharia, Y., Tripathi, N., Agarwal, N., Dawsey, S., Gupta, S., Lu, E., Drakaki, A., Liu, S., Zakopoulou, R., Bamias, A., Fulgenzi, C. -M., Cortellini, A., Pinato, D., Barata, P., Grivas, P., Khaki, A. R., Koshkin, V. S.
مصطلحات موضوعية: Bladder cancer, Immunotherapy, Urinary tract cancer, urothelial cancer
Relation: info:eu-repo/semantics/altIdentifier/pmid/36481176; info:eu-repo/semantics/altIdentifier/wos/WOS:000966223500001; volume:21; issue:2; firstpage:286; lastpage:294; numberofpages:9; journal:CLINICAL GENITOURINARY CANCER; https://hdl.handle.net/11579/159427; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85143894540
-
2Academic Journal
المؤلفون: Talukder R., Makrakis D., Lin G. I., Diamantopoulos L. N., Dawsey S., Gupta S., Carril-Ajuria L., Castellano D., de Kouchkovsky I., Jindal T., Koshkin V. S., Park J. J., Alva A., Bilen M. A., Stewart T. F., McKay R. R., Tripathi N., Agarwal N., Vather-Wu N., Zakharia Y., Morales-Barrera R., Devitt M. E., Cortellini A., Fulgenzi C. A. M., Pinato D. J., Nelson A., Hoimes C. J., Gupta K., Gartrell B. A., Sankin A., Tripathi A., Zakopoulou R., Bamias A., Murgic J., Frobe A., Rodriguez-Vida A., Drakaki A., Liu S., Lu E., Kumar V., Lorenzo G. D., Joshi M., Isaacsson-Velho P., Buznego L. A., Duran I., Moses M., Barata P., Sonpavde G., Wright J. L., Yu E. Y., Montgomery R. B., Hsieh A. C., Grivas P., Khaki A. R.
المساهمون: Talukder, R., Makrakis, D., Lin, G. I., Diamantopoulos, L. N., Dawsey, S., Gupta, S., Carril-Ajuria, L., Castellano, D., de Kouchkovsky, I., Jindal, T., Koshkin, V. S., Park, J. J., Alva, A., Bilen, M. A., Stewart, T. F., Mckay, R. R., Tripathi, N., Agarwal, N., Vather-Wu, N., Zakharia, Y., Morales-Barrera, R., Devitt, M. E., Cortellini, A., Fulgenzi, C. A. M., Pinato, D. J., Nelson, A., Hoimes, C. J., Gupta, K., Gartrell, B. A., Sankin, A., Tripathi, A., Zakopoulou, R., Bamias, A., Murgic, J., Frobe, A., Rodriguez-Vida, A., Drakaki, A., Liu, S., Lu, E., Kumar, V., Lorenzo, G. D., Joshi, M., Isaacsson-Velho, P., Buznego, L. A., Duran, I., Moses, M., Barata, P., Sonpavde, G., Wright, J. L., Yu, E. Y., Montgomery, R. B., Hsieh, A. C., Grivas, P., Khaki, A. R.
مصطلحات موضوعية: Bladder cancer, Checkpoint Inhibitor, Immunotherapy, Outcome, Platinum resistance
Relation: info:eu-repo/semantics/altIdentifier/pmid/36155169; info:eu-repo/semantics/altIdentifier/wos/WOS:000919659000016; volume:20; issue:6; firstpage:558; lastpage:567; numberofpages:10; journal:CLINICAL GENITOURINARY CANCER; https://hdl.handle.net/11579/159469; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85138769237
-
3Academic Journal
المؤلفون: Makrakis D., Talukder R., Lin G. I., Diamantopoulos L. N., Dawsey S., Gupta S., Carril-Ajuria L., Castellano D., de Kouchkovsky I., Koshkin V. S., Park J. J., Alva A., Bilen M. A., Stewart T. F., McKay R. R., Tripathi N., Agarwal N., Vather-Wu N., Zakharia Y., Morales-Barrera R., Devitt M. E., Cortellini A., Fulgenzi C. A. M., Pinato D. J., Nelson A., Hoimes C. J., Gupta K., Gartrell B. A., Sankin A., Tripathi A., Zakopoulou R., Bamias A., Murgic J., Frobe A., Rodriguez-Vida A., Drakaki A., Liu S., Lu E., Kumar V., Lorenzo G. D., Joshi M., Isaacsson-Velho P., Buznego L. A., Duran I., Moses M., Jang A., Barata P., Sonpavde G., Yu E. Y., Montgomery R. B., Grivas P., Khaki A. R.
المساهمون: Makrakis, D., Talukder, R., Lin, G. I., Diamantopoulos, L. N., Dawsey, S., Gupta, S., Carril-Ajuria, L., Castellano, D., de Kouchkovsky, I., Koshkin, V. S., Park, J. J., Alva, A., Bilen, M. A., Stewart, T. F., Mckay, R. R., Tripathi, N., Agarwal, N., Vather-Wu, N., Zakharia, Y., Morales-Barrera, R., Devitt, M. E., Cortellini, A., Fulgenzi, C. A. M., Pinato, D. J., Nelson, A., Hoimes, C. J., Gupta, K., Gartrell, B. A., Sankin, A., Tripathi, A., Zakopoulou, R., Bamias, A., Murgic, J., Frobe, A., Rodriguez-Vida, A., Drakaki, A., Liu, S., Lu, E., Kumar, V., Lorenzo, G. D., Joshi, M., Isaacsson-Velho, P., Buznego, L. A., Duran, I., Moses, M., Jang, A., Barata, P., Sonpavde, G., Yu, E. Y., Montgomery, R. B., Grivas, P., Khaki, A. R.
مصطلحات موضوعية: Advanced urothelial carcinoma, Bladder cancer, Immune checkpoint inhibitor, Metastatic cancer, Outcomes
Relation: info:eu-repo/semantics/altIdentifier/pmid/35778337; info:eu-repo/semantics/altIdentifier/wos/WOS:001043904500012; volume:20; issue:5; firstpage:440; lastpage:452; numberofpages:13; journal:CLINICAL GENITOURINARY CANCER; https://hdl.handle.net/11579/159421; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85133310824